High Incidence of Point Mutations of P53 Suppressor Oncogene in Patients With Myelodysplastic Syndrome Among Atomic-Bomb Survivors: A 10-Year Follow-Up

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402277
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search